OXFORD BIOMEDICAL RESEARCH, INC.

Basic Information

2165 AVON INDUSTRIAL DRIVE
ROCHESTER HILLS, MI, 48309-

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Advanced GST Proteomics for Early Stage Organ-Specific Toxicity Screening. Phase

    Amount: $1,163,577.00

    DESCRIPTION: Biomarkers currently employed for the detection of organ toxicity are often not sensitive enough to detect the early stages of acute organ damage, i.e. at a stage when reducing or elimin ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. Advanced GST Proteomics for Early Stage Organ-Specific Toxicity Screening

    Amount: $117,685.00

    DESCRIPTION (provided by applicant): Current biomarkers employed in the detection of organ toxicity are often not sensitive enough to detect the early stages of acute organ damage, i.e. at a stage whe ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. QCM Quantification of Endocrine Disruptor Activity

    Amount: $85,395.00

    DESCRIPTION (provided by applicant): Environmental agents with estrogen-like activity are a major public health issue. Although a variety of assays have been developed to detect binding to the estroge ...

    STTR Phase I 2004 Department of Health and Human Services
  4. Transcription Factor markers- cellular oxidative stress

    Amount: $0.00

    DESCRIPTION (provided by applicant): Accumulating evidence suggests that sustained oxidative stress affects many biochemical and molecular processes and is responsible for altered metabolic functions ...

    SBIR Phase I 2003 Department of Health and Human Services
  5. Transcription Factor markers- cellular oxidative stress

    Amount: $496,014.00

    DESCRIPTION (provided by applicant): Accumulating evidence suggests that sustained oxidative stress affects many biochemical and molecular processes and is responsible for altered metabolic functions ...

    SBIR Phase II 2003 Department of Health and Human Services
  6. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 2003 Department of Health and Human Services
  7. N/A

    Amount: $138,131.00

    N/A

    SBIR Phase II 2003 Department of Health and Human Services
  8. Organ Specific Damage Assessment Biomarker Assays

    Amount: $0.00

    DESCRIPTION (provided by applicant): Biomarkers that accurately reflect acute and/or past exposure to harmful agents are crucial in any study aiming to reduce the incidence of diseases resulting from ...

    SBIR Phase I 2003 Department of Health and Human Services
  9. Organ Specific Damage Assessment Biomarker Assays

    Amount: $710,033.00

    DESCRIPTION (provided by applicant): Biomarkers that accurately reflect acute and/or past exposure to harmful agents are crucial in any study aiming to reduce the incidence of diseases resulting from ...

    SBIR Phase II 2003 Department of Health and Human Services
  10. DEVELOPMENT OF SURROGATE BIOMARKERS FOR SAFETY EVALUATION OF CHEMICALS:

    Amount: $35,763.00

    N/A

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government